Please try another search
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Jacqualyn A. Fouse | 61 | 2017 | Chair of the Board of Directors |
Brian M. Goff | 54 | 2022 | CEO & Director |
Kaye I. Foster-Cheek | 63 | 2014 | Lead Independent Director |
Scott A. Biller | 68 | 2010 | Member of Scientific Advisory Board |
Matthew Vander Heiden | - | 2008 | Member of Scientific Advisory Board |
David P. Schenkein | 67 | 2009 | Independent Director |
Marc Tessier-Lavigne | 64 | 2011 | Member of Scientific Advisory Board |
David T. Scadden | 71 | 2017 | Independent Director |
Cynthia Smith | 55 | 2022 | Independent Director |
Maykin Ho | 71 | 2015 | Independent Director |
Charles L. Sawyers | 65 | 2009 | Member of Scientific Advisory Board |
Ralph Deberardinis | - | - | Member of Scientific Advisory Board |
Joan S. Brugge | - | - | Member of Scientific Advisory Board |
Rahul D. Ballal | 46 | 2022 | Independent Director |
Jeffrey D. Capello | 59 | 2023 | Independent Director |
Catherine E. Owen | 53 | 2023 | Independent Director |
Shin-San Su | 68 | - | Co-Founder & Member of Scientific Advisory Board |
Craig B. Thompson | 71 | - | Co-Founder & Chairman of Scientific Advisory Board |
Lewis Clayton Cantley | 75 | 2007 | Co-Founder & Member of Scientific Advisory Board |
Tak Wah Mak | 78 | - | Co-Founder & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review